Company intelligence / Profile preview
Deurali-Janta Pharmaceuticals
Kathmandu, Bagmati, Nepaldeuralijanta.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Deurali-Janta Pharmaceuticals is Nepal’s largest pharmaceutical manufacturer, with WHO-GMP and ISO certifications, offering over 250 commercial products across cardiovascular, endocrinology, neuropsychiatry, nephrology, dermatology, gastrology, women & child health, and general medicine segments, and is focused on expanding to international markets[1][3][8].
- Therapeutic areas
- CardiovascularImmunologyEndocrinologyRheumatologyGastroenterologyInfectious DiseasesPulmonologyWomen's HealthHematologyDermatologyPsychiatry
- Modalities
- Small moleculeBiologicProteinVaccineAntibiotic (as product class)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
RENATA (technology transfer partner, Bangladesh)
Beyond the preview
Go deeper on Deurali-Janta Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Deurali-Janta Pharmaceuticals.